All In Biotech

Drug Trial Radar · NCT05776277

Iltamiocel Compared to Placebo for Chronic Fecal Incontinence in Females With Obstetric Injury

A Two-stage, Randomized, Controlled Trial Comparing the Safety and Efficacy of Iltamiocel With Placebo in the Treatment of Female Participants With Chronic Fecal Incontinence and a History of Obstetric Anal Sphincter Injury (DigniFI)

Last checked: Nov 19, 2026Latest source record: Oct 20, 2026 (this record)Source: ClinicalTrials.govMethods & limitations

Active, not recruitingPivotal-lookingPhase 3. Randomized with 200 participants. This is a heuristic, not a regulatory label.

Status

Active, not recruiting

Enrollment

200

Planned (sponsor's estimate)

Start

Mar 21, 2024

Primary completion

Dec 2026

Study completion Dec 2027

Sponsor

Lead sponsor
Cook MyoSiteIndustry
Sponsor type
Industry
First posted
Mar 20, 2023

More drug trials from this sponsor

Design

Study type
Interventional
Phase
Phase 3
Allocation
Randomized
Model
Parallel
Masking
Quadruple (participant, care provider, investigator, outcomes assessor)
Primary purpose
Treatment
FDA-regulated drug
Yes
Who can join
Female only, from 18 years
Healthy volunteers
No

Summary

As written by the sponsor on the registry.

This study evaluates the efficacy and safety of a single injection of iltamiocel (300 x 10\^6 cells) compared to a placebo in the reduction of fecal incontinence episode frequency in adult female participants with chronic fecal incontinence and a history of obstetric anal sphincter injury. Half of the participants will receive iltamiocel (injections with cells) and the other half will receive placebo.

Conditions

  • Fecal Incontinence

Interventions

  • IltamiocelBiological

    Single external anal sphincter (EAS) injection of 300 x 10\^6 cells.

  • PlaceboOther

    Placebo control is the vehicle solution used for the study product.

Primary outcomes

What the sponsor says the trial is designed to measure.

  1. Changes in frequency of fecal incontinence episodes.Time frame: 12 Months

Locations

25 sites in 1 country. Site status is shown where the registry gives one.

  • UC San Diego Health

    La Jolla, California

  • UC Irvine Medical Center

    Orange, California

  • University of California, San Francisco - Center for Colorectal Surgery

    San Francisco, California

  • Prestige Medical Group

    Tustin, California

  • American Association of Female Pelvic Medicine

    Westlake Village, California

  • University of Florida Shands Hospital

    Gainesville, Florida

  • Healthcare Clinical Data, Inc.

    Miami, Florida

  • Orlando Health Colon & Rectal Institute

    Orlando, Florida

  • USF Health South Tampa Center for Advanced Healthcare

    Tampa, Florida

  • Colorectal Wellness Center

    Fayetteville, Georgia

  • University of Illinois

    Chicago, Illinois

  • Franciscan Health Indianapolis

    Indianapolis, Indiana

  • Ochsner Health

    New Orleans, Louisiana

  • Massachusetts General Hospital

    Boston, Massachusetts

  • Bennett Institute of Urogynecology and Incontinence

    Grand Rapids, Michigan

  • University of Minnesota

    Minneapolis, Minnesota

  • Mayo Clinic

    Rochester, Minnesota

  • Washington University School of Medicine

    St Louis, Missouri

  • Rutgers, Robert Wood Johnson Medical School, Clinical Research Center

    New Brunswick, New Jersey

  • Westchester Medical Center

    Hawthorne, New York

  • The Mount Sinai Medical Center

    New York, New York

  • Weill Cornell Medicine

    New York, New York

  • Stony Brook University Hospital

    Stony Brook, New York

  • Cleveland Clinic Main Campus Crile Building

    Cleveland, Ohio

  • Rhode Island Hospital

    Providence, Rhode Island

Contact details for sites and study staff are not shown here. To ask about taking part, use the contact information on the registry record.

For information only. Nothing on this page is investment, legal, tax or medical advice, and nothing here is an offer to sell or a solicitation of an offer to buy any security. The data comes from public government sources, which can be incomplete, delayed or wrong. Check the original record before relying on it.